With high interest have we read the article by Vignes et al., recording complications (lymphoedema, lymphocoele, hydrocoele and donor-site pain) in patients undergoing autologous lymph node transplantation (ALNT) for limb lymphoedema. 1 In addition, we recently witnessed a fatal case of angiosarcoma in a 21-year-old woman. We were amazed by the unusual presentation of this aggressive tumour in such a young otherwise healthy woman, located in the right groin exactly at the site of ALNT performed 14 and 7 years before.
This patient had a painful lump on the right thigh that had increased in size over a year ( Fig. 1 ). She had had primary lymphoedema of the right part of body since she was 3 months old. She had had ALNT in the right groin at the age of 7 years repeated at the age of 15 years. The histological diagnosis of this lump was a cutaneous epithelioid angiosarcoma. The patient died from pleural metastases 3 months later.
Occurrence of angiosarcoma in a primary lymphoedema remains a rare event. The mechanisms for development of lymphoedema-associated angiosarcoma may involve local disturbance of angiogenesis. Lymphatic impairment may contribute to excessive production of pro-angiogenic cytokines from the Vascular Endothelial Growth Factor (VEGF) family, and VEGFs are overexpressed in most angiosarcomas. 2 ALNT could have enhanced local production of angiogenic growth factors and thus development of the angiosarcoma. There is increased expression of VEGF at the recipient site after such surgery, 3 and in a study of patients 4 with ALNT, VEGF-C mRNA expression in human lymph nodes was found to be higher than in other tissues.
As a conclusion, ALNT also raises concerns regarding the potential risk of neoplasia. The safety of these procedures cannot be presumed before long term observational cohort studies have taken place.
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